Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation
- PMID: 20501853
- DOI: 10.1158/0008-5472.CAN-09-3258
Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation
Abstract
The N-acetyltransferase arrest defective 1 (ARD1) is an important regulator of cell growth and differentiation that has emerged recently as a critical molecule in cancer progression. However, the regulation of the enzymatic and biological activities of human ARD1 (hARD1) in cancer is presently poorly understood. Here, we report that hARD1 undergoes autoacetylation and that this modification is essential for its functional activation. Using liquid chromatography-tandem mass spectrometry and site-directed mutational analyses, we identified K136 residue as an autoacetylation target site. K136R mutation abolished the ability of hARD1 to promote cancer cell growth in vitro and tumor xenograft growth in vivo. Mechanistic investigations revealed that hARD1 autoacetylation stimulated cyclin D1 expression through activation of the transcription factors beta-catenin and activator protein-1. Our results show that hARD1 autoacetylation is critical for its activation and its ability to stimulate cancer cell proliferation and tumorigenesis.
Copyright 2010 AACR.
Similar articles
-
Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.Cancer Res. 2006 Nov 15;66(22):10677-82. doi: 10.1158/0008-5472.CAN-06-3171. Cancer Res. 2006. PMID: 17108104
-
Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.Int J Oncol. 2015 Jan;46(1):99-106. doi: 10.3892/ijo.2014.2708. Epub 2014 Oct 17. Int J Oncol. 2015. PMID: 25338643
-
The protein acetyltransferase ARD1: a novel cancer drug target?Curr Cancer Drug Targets. 2008 Nov;8(7):545-53. doi: 10.2174/156800908786241113. Curr Cancer Drug Targets. 2008. PMID: 18991565 Review.
-
Different subcellular localizations and functions of human ARD1 variants.Int J Oncol. 2015 Feb;46(2):701-7. doi: 10.3892/ijo.2014.2770. Epub 2014 Nov 21. Int J Oncol. 2015. PMID: 25421966
-
Diverse roles of arrest defective 1 in cancer development.Arch Pharm Res. 2019 Dec;42(12):1040-1051. doi: 10.1007/s12272-019-01195-0. Epub 2019 Dec 7. Arch Pharm Res. 2019. PMID: 31813105 Review.
Cited by
-
Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.Molecules. 2020 Jan 29;25(3):588. doi: 10.3390/molecules25030588. Molecules. 2020. PMID: 32013195 Free PMC article.
-
Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.J Cell Mol Med. 2021 Jul;25(14):6760-6772. doi: 10.1111/jcmm.16680. Epub 2021 May 31. J Cell Mol Med. 2021. PMID: 34060226 Free PMC article.
-
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.Exp Mol Med. 2018 Jul 27;50(7):1-12. doi: 10.1038/s12276-018-0106-1. Exp Mol Med. 2018. PMID: 30054466 Free PMC article. Review.
-
A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.J Med Genet. 2014 Mar;51(3):185-96. doi: 10.1136/jmedgenet-2013-101660. Epub 2014 Jan 15. J Med Genet. 2014. PMID: 24431331 Free PMC article.
-
Dynamics-function relationship in the catalytic domains of N-terminal acetyltransferases.Comput Struct Biotechnol J. 2020 Mar 3;18:532-547. doi: 10.1016/j.csbj.2020.02.017. eCollection 2020. Comput Struct Biotechnol J. 2020. PMID: 32206212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous